| Delayed Japan Exchange 07:00:02 16/07/2024 BST | 5-day change | 1st Jan Change | ||
| 2,904 PTS | +0.34% |
|
+0.31% | +22.74% |
| 07-16 | Daiwa House REIT Investment Completes 3 Billion Yen Buyback Program | MT |
| 07-16 | Copro-Holdings Technical Employees Increases to 3,961 in June | MT |
BENGALURU/HYDERABAD (Reuters) - Indian generic drugmaker Cipla posted a bigger-than-expected 32% rise in third-quarter profit on Monday, driven by strong performance in its North American business.
Consolidated net profit climbed to 10.56 billion Indian rupees ($127.1 million) in the quarter ended Dec. 31, beating analysts' average estimate of 10.43 billion rupees, as per LSEG data.
($1 = 83.1050 Indian rupees)
(Reporting by Kashish Tandon and Varun Vyas in Bengaluru, Rishika Sadam in Hyderabad; Editing by Anil D'Silva)
Highest TOPIX Index increases |
|
|---|---|
| +16.72% | |
| +14.39% | |
| +13.78% | |
| +13.00% | |
| +12.07% |
The sharpest declines in TOPIX Index. |
|
|---|---|
| -9.05% | |
| -12.20% | |
| -14.44% | |
| -15.47% | |
| -16.01% |
TOPIX INDEX 
